These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications. Triposkiadis F; Karayannis G; Giamouzis G; Skoularigis J; Louridas G; Butler J J Am Coll Cardiol; 2009 Nov; 54(19):1747-62. PubMed ID: 19874988 [TBL] [Abstract][Full Text] [Related]
5. Neurohormonal activation in congestive heart failure and the role of vasopressin. Chatterjee K Am J Cardiol; 2005 May; 95(9A):8B-13B. PubMed ID: 15847852 [TBL] [Abstract][Full Text] [Related]
6. Humoral factors in chronic heart failure. A review. Kölbel F Cor Vasa; 1992; 34(1):67-70. PubMed ID: 1337731 [TBL] [Abstract][Full Text] [Related]
7. [Renal sequelae of sympathetic hyperactivity]. Watschinger B; Habicht A Wien Med Wochenschr; 2004; 154 Spec No 1(1):7-9. PubMed ID: 15346546 [No Abstract] [Full Text] [Related]
10. The effects of dobutamine on renal sympathetic activity in human heart failure. Al-Hesayen A; Parker JD J Cardiovasc Pharmacol; 2008 May; 51(5):434-6. PubMed ID: 18398381 [TBL] [Abstract][Full Text] [Related]
11. Just the berries. Management of heart failure. Ruggles L Can Fam Physician; 2001 Mar; 47():499-501. PubMed ID: 11281082 [No Abstract] [Full Text] [Related]
12. [Chronic heart failure (IV). The neurohormonal factors in chronic heart failure. Their clinical importance and therapeutic implications]. Rayo I; Marín Huerta E Rev Esp Cardiol; 1991 Dec; 44(10):656-71. PubMed ID: 1686945 [No Abstract] [Full Text] [Related]
13. [The renin-angiotensin system and drugs]. Saruta T Nihon Rinsho; 1982; 40(9):2059-66. PubMed ID: 6130174 [No Abstract] [Full Text] [Related]
15. Vitamin C restores the contractile response to dobutamine and improves myocardial efficiency in patients with heart failure after anterior myocardial infarction. Shinke T; Shite J; Takaoka H; Hata K; Inoue N; Yoshikawa R; Matsumoto H; Masai H; Watanabe S; Ozawa T; Otake H; Matsumoto D; Hirata K; Yokoyama M Am Heart J; 2007 Oct; 154(4):645.e1-8. PubMed ID: 17892985 [TBL] [Abstract][Full Text] [Related]
16. [Chronic cardiac insufficiency: current treatment and future outlook]. Reuge L; Metzger J; Burri M; Kehtari R Rev Med Suisse Romande; 1996 Jun; 116(6):441-50. PubMed ID: 8711295 [No Abstract] [Full Text] [Related]
17. [Refractory heart failure: it requires the use of polychemotherapy. What is the rationale?]. Campa PP; Puddu PE; Schiariti M; Monti F; Dawodu AA; Gentile C; Lilla Della Monica PL; Vaccaro M; De Biase L Cardiologia; 1995 Dec; 40(12 Suppl 1):139-50. PubMed ID: 8998706 [No Abstract] [Full Text] [Related]
18. Cardiac glycosides in the next millennium. Hauptman PJ; Garg R; Kelly RA Prog Cardiovasc Dis; 1999; 41(4):247-54. PubMed ID: 10362347 [TBL] [Abstract][Full Text] [Related]
19. Determinants of increased angiotensin II levels in severe chronic heart failure patients despite ACE inhibition. van de Wal RM; Plokker HW; Lok DJ; Boomsma F; van der Horst FA; van Veldhuisen DJ; van Gilst WH; Voors AA Int J Cardiol; 2006 Jan; 106(3):367-72. PubMed ID: 16337046 [TBL] [Abstract][Full Text] [Related]
20. [Sympathetic nervous system in heart failure: effect of catecholamines and nitric oxide]. Drexler H Z Kardiol; 1996; 85 Suppl 6():247-52. PubMed ID: 9064972 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]